Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”
Rhea-AI Summary
Kestra Medical Technologies (Nasdaq: KMTS) was named a finalist for the 2026 GeekWire Awards “Deal of the Year” for its successful 2025 initial public offering. The recognition cites impactful transactions and highlights Kestra’s expanding Pacific Northwest presence and commercial growth of its Cardiac Recovery System®.
Community voting runs through April 16, 2026, with winners announced at the GeekWire Awards ceremony on May 7, 2026 in Seattle.
Positive
- None.
Negative
- None.
News Market Reaction – KMTS
In the Mar 25 session, KMTS declined 0.58%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Mar 17 | Earnings results | Positive | -7.4% | Strong Q3 FY2026 growth and raised FY26 revenue guidance with higher cash. |
| Mar 03 | Earnings date | Neutral | +0.8% | Announcement of Q3 FY2026 earnings release date and conference call details. |
| Jan 13 | Strategic partnership | Positive | -5.8% | Collaboration with Biobeat to add cuffless ABPM into ASSURE WCD ecosystem. |
| Dec 30 | Conference appearance | Neutral | +2.0% | Planned presentation at the J.P. Morgan Healthcare Conference with webcast access. |
| Dec 11 | Earnings results | Positive | +5.1% | Q2 FY2026 revenue growth, margin expansion, raised guidance, and stronger cash. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Positive fundamental or partnership news has sometimes seen negative next-day reactions, but not consistently; reactions to earnings and events have been mixed.
Recent news shows KMTS executing on growth and capital markets milestones. On Dec 11, 2025 and Mar 17, 2026, earnings highlighted strong revenue growth and margin expansion, but one report drew a -7.38% reaction. A Jan 13, 2026 collaboration with Biobeat brought clinical integration but saw a -5.85% move. Conference participation and an earnings-date notice had mild positive impacts. Today’s GeekWire award finalist news fits into a narrative of growing brand and ecosystem visibility.
Key Terms
initial public offering financial
sudden cardiac arrest medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
KIRKLAND, Wash., March 25, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced it has been named a finalist in the “Deal of the Year” category for the 2026 GeekWire Awards. Now in its 15th year, the annual awards recognize companies and leaders shaping the Pacific Northwest technology ecosystem, where Kestra continues to expand its presence.
The “Deal of the Year” category recognizes impactful transactions including acquisitions, financings, and public offerings. Kestra was named a finalist for its successful 2025 initial public offering, a milestone that supports continued commercial expansion and innovation across its Cardiac Recovery System® platform.
“This recognition highlights the momentum we’re building as we scale Kestra,” said Brian Webster, President and Chief Executive Officer. “Our IPO strengthened our ability to invest in growth and accelerate our progress toward a new standard of care for patients at risk of sudden cardiac arrest.”
Finalists were selected through a multi-stage nomination and judging process involving the regional technology community. Community voting is open through April 16, 2026, and winners will be announced at the GeekWire Awards ceremony on May 7, 2026, in Seattle. To vote, visit: https://www.surveymonkey.com/r/BJQ2PM9
About Kestra
Kestra Medical Technologies is a leading wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. For more information, please visit www.kestramedical.com.
Media contact Rhiannon Pickus rhiannon.pickus@kestramedical.com